2023. COMPARATIVE ASSESSMENT OF GEFITINIB AND ERLOTINIB THERAPY IN SUBJECTS WITH NON-SMALL CELL LUNG CARCINOMA. International Research Journal of Pharmacy. 14, 9 (Sep. 2023), 1–5.